Advertisement
Advertisement
CCCC
C4 Therapeutics, Inc.
1.81
USDSponsored
+0.10
+6.02%
Feb 06, 15:59 UTC -5
Closed
After-Market
1.80
-0.01
-0.44%
CCCC Earnings Reports
Positive Surprise Ratio
CCCC beat 13 of 21 last estimates.
62%
Next Report
Date of Next Report
Feb 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$6.59M
/-$0.30
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
+27.28%
/-38.78%
C4 Therapeutics, Inc. earnings per share and revenue
On --, CCCC reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.30 USD, with revenue projected to reach 6.59 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Biogen Inc. Common Stock
Report Date
Feb 06, 2026 For Q4 25
Estimate
$1.62
Actual
$1.99
Surprise
+22.39%
Illumina Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.24
Actual
$1.35
Surprise
+8.01%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Arrowhead Research Corporation
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.25
Actual
$0.22
Surprise
-14.76%
Immunovant, Inc. Common Stock
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.61
Surprise
+16.27%
Adaptive Biotechnologies Corporation Common Stock
Report Date
Feb 05, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.09
Surprise
+51.33%
FAQ
What were C4 Therapeutics, Inc.'s earnings and revenue for the latest quarter Q-- --?
For Q-- --, C4 Therapeutics, Inc. reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to C4 Therapeutics, Inc.'s Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is C4 Therapeutics, Inc. expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for C4 Therapeutics, Inc.'s next earnings report?
Based on 9
analysts, C4 Therapeutics, Inc. is expected to report EPS of -$0.30 and revenue of $6.59M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement